Cargando…
Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
BACKGROUND: While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users. METHODS: We cond...
Autores principales: | Shover, Carolyn M., Yan, Peter, Jackson, Nicholas J., Buhr, Russell G., Fulcher, Jennifer A., Tashkin, Donald P., Barjaktarevic, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356466/ https://www.ncbi.nlm.nih.gov/pubmed/35932069 http://dx.doi.org/10.1186/s42238-022-00152-x |
Ejemplares similares
-
Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis
por: Toppen, William, et al.
Publicado: (2022) -
Eosinophil Recovery in Hospitalized COVID-19 Patients is Associated with Lower Rates of ICU Admission and In-Hospital Mortality: An Observational Cohort Analysis
por: Yan, Peter D., et al.
Publicado: (2023) -
How Differential Are the Effects of Smoking Cannabis versus Tobacco on Lung Function?
por: Tashkin, Donald P., et al.
Publicado: (2022) -
Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023) -
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD
por: Park, Seon Cheol, et al.
Publicado: (2023)